What is Tremelimumab?

Category: Prescription Drugs

false

Tremelimumab (formerly ticilimumab, CP-675,206) is an antibody that is in clinical trials for several different types of cancer.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
0
Mild
0
None
0

Commonly reported side effects and conditions associated with Tremelimumab

Side effect Patients
Fatigue 1
Last updated:
There are no evaluations for Tremelimumab.